📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary. (2023)

First Author: Klatte T

Attributed to: Cambridge Mathematics of Information in Healthcare (CMIH) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bju.15966

PubMed Identifier: 36638048

Publication URI: http://europepmc.org/abstract/MED/36638048

Type: Journal Article/Review

Volume: 131

Parent Publication: BJU international

Issue: 5

ISSN: 1464-4096